TITLE

Efficacy of an Interleukin-1β Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis

AUTHOR(S)
Scardapane, Alessandra; Brucato, Antonio; Chiarelli, Francesco; Breda, Luciana
PUB. DATE
December 2013
SOURCE
Pediatric Cardiology;Dec2013, Vol. 34 Issue 8, p1989
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Pericarditis may recur in up to 30 % of adult patients, but recurrent pericarditis is a rare disease in childhood. The etiology of the initial attack and the causes of recurrences often remain unknown. Recurrent pericarditis is accompanied by a high morbidity rate and may represent a challenge to the clinician due to problems in management. Therapeutic strategies are not specific and include nonsteroidal antiinflammatory drugs, corticosteroids, immunosuppressive drugs, colchicine, and pericardiectomy. Controlled trials have demonstrated that colchicine can reduce the recurrent rate of pericarditis, whereas early corticosteroid therapy promotes recurrences. Anakinra, a recombinant human interleukin-1β receptor antagonist, is a promising new biologic agent for the treatment of autoinflammatory diseases such as cryopyrinopathies, tumor necrosis factor receptor-associated periodic syndrome, and hyperimmunoglobulinemia D with periodic fever syndrome. This report describes an 11-year-old boy successfully treated with anakinra for a steroid-dependent recurrent pericarditis unresponsive to conventional treatment.
ACCESSION #
91907479

 

Related Articles

  • Colchicine.  // Reactions Weekly;1/30/2016, Vol. 1586 Issue 1, p103 

    An abstract of the article "The pregnancy outcomes in FMF patients who are exposed to IL-1 blockade with anakinra" by H. Ozdogan and others is presented.

  • Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever. Cetin, Pinar; Sari, Ismail; Sozeri, Betul; Cam, Ozlem; Birlik, Merih; Akkoc, Nurullah; Onen, Fatos; Akar, Servet // Inflammation;Feb2015, Vol. 38 Issue 1, p27 

    Herein, we reported our experience in colchicine-resistant familial Mediterranean fever (FMF) patients who are treated with anti-interleukin-1 (IL-1) drugs. A retrospective review of medical records of anti-IL-1 recipients was performed. The main clinical characteristics of these patients and...

  • A possible role of IL-1RN gene polymorphism in the outcome of gastrointestinal diseases associated with H. pylori infection. Mattar, Rejane; Marques, Sergio Barbosa; dos Santos, Anibal Ferreira; Socorro Monteiro, Maria do; Iriya, Kiyoshi; Carrilho, Flair José // Clinical & Experimental Gastroenterology;Apr2013, Vol. 6, p35 

    Objective: To verify whether the variable number of tandem repeat (VNTR) polymorphism in the IL-1RN gene that encodes the interleukin (IL)-1 receptor antagonist (IL-1Ra) plays a role in the outcome of gastrointestinal diseases associated with Helicobacter pylori (H. pylori) infection. Methods:...

  • Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra-case report and review. Hennig, Stefanie; Bayegan, Keywan; Uffmann, Martin; Thalhammer, Florian; Winkler, Stefan // Rheumatology International;Jun2012, Vol. 32 Issue 6, p1801 

    We report the case of a 35-years-old renal transplant patient known to have familial Mediterranean fever with serum amyloid A (SAA)-amyloidosis, who presented with his second episode of bilateral pneumonia. As antimicrobials failed to control the first episode of pneumonia and all studies done...

  • Clozapine.  // Reactions Weekly;1/29/2011, Issue 1336, p15 

    The article describes the case of a 32-year-old man who developed pericarditis after receiving clozapine for schizophrenia.

  • Meglumine antimonate.  // Reactions Weekly;5/22/2010, Issue 1302, p33 

    The article describes the case of a 49-year old man who developed pericarditis following the administration of meglumine antimonate for cutaneous leishmaniasis.

  • Hydralazine.  // Reactions Weekly;Feb2014, Vol. 1488 Issue 1, p22 

    The article presents a case study of a 60-year old man who developed pericarditis secondary to lupus during treatment with hydralazine.

  • IRAK1, a potential therapeutic target for rheumatoid arthritis? Xie, Qiang; Wang, Shi-Cun; Li, Jun // Rheumatology International;Dec2013, Vol. 33 Issue 12, p3069 

    A letter to the editor which discusses the association of Interleukin-1 receptor-associated kinase 1 enzyme with the autoimmune disease rheumatoid arthritis is presented.

  • Chronic mitral-aortic fibrosa pseudoaneurysm after aortic valve replacement. Bittencourt, Marcio Sommer; Hulten, Edward; Blankstein, Ron; Steigner, Michael // European Journal of Cardio-Thoracic Surgery;Dec2012, Vol. 42 Issue 6, p1052 

    The article presents a case study of 67-year-old male patient with tuberculous pericarditis who underwent pericardiectomy and two prior aortic valve replacements and found to have a posterior aortic pseudoaneurysm in a transoesophageal echocardiogram.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics